Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$12.90 USD
-0.31 (-2.35%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $12.95 +0.05 (0.39%) 7:40 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
RIGL 12.90 -0.31(-2.35%)
Will RIGL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RIGL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RIGL
Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates
Profound Medical (PROF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
RIGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aurinia Pharmaceuticals (AUPH) Q2 Earnings and Revenues Beat Estimates
Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?
Rigel Pharmaceuticals (RIGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for RIGL
Rigel Pharmaceuticals, Inc. (RIGL) Q2 2024 Earnings Call Transcript
Analysts Offer Insights on Healthcare Companies: Rigel (RIGL) and IDEAYA Biosciences (IDYA)
Rigel Pharmaceuticals price target raised by $15.25 at B. Riley, here's why
Rigel Pharmaceuticals target adjusted to $57 from $15 at H.C. Wainwright
Rigel Pharmaceuticals Inc (RIGL) Q2 2024 Earnings Call Transcript Highlights: Strong Sales ...